查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1858137

急診無針連接器市場：按材料、最終用戶、連接器類型、應用和分銷管道分類 - 全球預測 2025-2032

Acute Care Needleless Connectors Market by Material, End User, Connector Type, Application, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，急診無針連接器市場將成長至 11.9731 億美元，複合年成長率為 7.59%。

關鍵市場統計數據
基準年 2024 6.6655億美元
預計年份：2025年 7.1829億美元
預測年份 2032 11.9731億美元
複合年成長率 (%) 7.59%

無針連接器已成為急診環境中安全血管通路的核心，影響整個醫療保健系統的臨床工作流程、感染控制措施和採購決策。這些裝置能夠實現輸液和抽血等治療的頻繁通路，同時降低與針頭使用相關的風險。隨著臨床醫生和供應鏈負責人面臨預算日益緊張以及對安全性和可靠性要求不斷提高的挑戰，了解裝置的特性、相容性要求和生命週期考量變得愈發重要。

近年來，設計改進的重點在於防止洩漏、易於消毒以及與標準化連接系統的兼容性。這些工程技術的進步與不斷發展的臨床通訊協定相契合，旨在減少中心靜脈導管相關血流感染並最佳化輸注精確度。因此，相關人員必須權衡臨床效能、設備成本、法規遵循以及與現有輸注平台的整合性。

本導言透過重點闡述推動無針連接器市場發展的臨床需求和採購現實，為後續分析奠定了基礎。同時，它也為接下來的詳細討論做好了鋪墊，包括市場變化、關稅影響、細分市場動態、區域行為和戰略應對措施，從而在深入探討具體研究結果和建議之前，為讀者提供清晰的框架。

醫療器材創新、感染控制預期和供應鏈策略的變革性轉變將再形成採購和臨床應用優先事項。

在技​​術改進、感染預防日益重視以及供應鏈重組的推動下，無針連接器領域正經歷著一場變革。材料和連接器幾何形狀的創新提高了相容性並減少了血液回流，而標準化魯爾介面和快速斷開選項的採用則加速了不同輸液系統間設備的互通性。同時，風險規避型臨床管治也提升了設備屬性的重要性，例如易於消毒和故障模式的可視性，促使採購者優先選擇那些能夠顯著降低污染風險的產品。

隨著製造商和醫療保健系統應對過去的供應鏈中斷和持續的地緣政治不確定性，供應鏈韌性已成為焦點。企業正日益多元化籌資策略，並對替代供應商進行資格認證，以降低單一供應商風險。監管也在同步發展，對醫療器材檢驗、上市後監測和不利事件透明度的要求更加明確。這種監管趨勢提升了能夠為醫療設備提供可靠臨床證據和可追溯性的供應商的價值。

總而言之，這些變化正在改變供應商的選擇標準，並加速能夠同時滿足臨床性能閾值和嚴格採購標準的供應商之間的整合。因此，醫療機構和製造商必須調整其在採購、研發和監管方面的策略，以保持競爭力。

評估美國關稅實施至2025年期間的累積營運和採購影響

2025年美國關稅調整為經銷商帶來了複雜的商業環境。這些政策變化改變了進口組件和零件的到岸成本，迫使先前嚴重依賴跨境採購的製造商重新評估其採購佈局。為此，一些製造商轉向近岸外包或雙重採購策略，以確保利潤率並維持可靠的交貨時間。

對於經銷商和醫院採購部門而言，關稅的增加增加了他們在不降低安全標準的前提下提供價值的壓力。合約談判越來越反映受關稅影響的商品，採購方也要求提高商品資訊的透明度，以便有效地模擬總體擁有成本。這促使臨床醫生和供應鏈團隊更加緊密地合作，以尋找在保持設備性能的同時，最大限度地降低財務影響的臨床等效替代方案。

監管和合規部門也會受到間接影響，因為製造地和供應鏈的變更需要更新文件，在某些情況下還需要額外的驗證工作。因此，那些主動重組製造地地點或投資供應鏈視覺化工具的組織能夠更順利地應對這些變化，從而維持服務水準並最大限度地減少臨床中斷。

整合材料選擇、終端用戶環境、連接器類型、臨床應用和通路的全面細分洞察

細分市場分析揭示了影響無針連接器產品選擇、購買行為和臨床應用的多個維度。材料選擇大致可分為金屬和塑膠兩大類，其中金屬材料主要為鋁和不銹鋼，兼具耐用性和熱穩定性；塑膠材料主要為聚碳酸酯和聚丙烯，兼顧強度、成本效益以及與一次性使用通訊協定的兼容性。這些材料差異會影響滅菌途徑、器械壽命以及臨床應用的可靠性認知。

終端使用者細分市場進一步明確了門診手術中心、家庭醫療保健和醫院環境的需求模式。門診手術中心包括醫生診所和門診診斷中心，這些場所的採購邏輯通常以吞吐量和一次性使用為主導。同時，家庭醫療保健環境又細分為家庭透析治療和居家輸液治療，這兩種情況都需要針對患者操作、易用性和更長的使用壽命進行最佳化的設備。醫院包括二級和三級醫療機構，這些機構優先考慮感染控制效果、與複雜輸液方案的整合以及與不同設備庫存的兼容性。

連接器類型是關鍵的功能區別，包括魯爾鎖式、魯爾滑式和快速斷開式三種選擇。魯爾鎖式和魯爾滑式又細分為母頭和公頭兩種配置，分別影響與注射器、導管和延長管的兼容性。快速斷開式設計則有單件式和兩件式兩種，強調快速連接和可靠密封，適用於頻繁操作的場景。血液採樣進一步區分動脈採樣和靜脈採樣；藥物輸送區分鎮痛藥、抗生素和化療；輸液治療區分Bolus和持續輸注，二者對性能的要求各不相同。

分銷通路細分透過辨識直銷通路、經銷商通路和線上通路，提供整體情況。經銷商包括服務於機構買家的醫療批發商和第三方分銷商，而線上管道則包括能夠快速補貨和處理小批量訂單的電商平台和製造商網站。每個通路對前置作業時間、服務水準和單據的要求各不相同，這反過來又會影響最終用戶群體的產品銷售和庫存方式。

影響美洲、歐洲、中東和非洲以及亞太地區需求模式的關鍵區域行為和採購動態

區域動態正在影響美洲、歐洲、中東和非洲以及亞太地區的產品偏好、監管重點和供應商策略。在美洲，大型一體化分銷網路和集中採購模式往往強調成本效益、與現有輸液平台的互通性以及供應商在當地提供穩定配送的能力。該地區更青睞那些兼具臨床證據和可擴展物流解決方案的產品。

歐洲、中東和非洲的監管和採購環境各不相同，各國的報銷政策、臨床通訊協定的差異以及供應鏈成熟度的差異都會影響產品的採用率。歐洲市場通常更注重嚴格的合格評定和臨床文件，而中東和非洲市場則可能更重視產品的可近性和對當地臨床實踐的適應性。這些差異要求供應商針對每個國家和地區調整其監管申報和商業性策略。

亞太地區呈現出獨特的市場動態，其醫療基礎設施快速擴張，居家醫療服務顯著成長，製造業實力雄厚。該地區部分市場傾向於選擇本地生產、價格具競爭力的產品，而有些市場則需要配備先進功能的高階設備，以滿足三級醫院的需求。在所有地區，與當地監管機構保持溝通以及與當地經銷商夥伴關係，對於成功進入市場並實現持續市場認可仍然至關重要。

策略競爭情報揭示領先製造商、專業創新者和供應合作夥伴如何透過設計、證據和服務實現差異化。

無針連接器領域主要企業的競爭格局反映了創新、規模和服務能力之間的平衡。市場領導者利用其豐富的產品系列、成熟的分銷網路和深厚的臨床證據，為大型機構客戶和多家醫院系統提供支援。這些公司致力於產品迭代改進、以用戶為中心的設計以及臨床研究，以證明其產品能夠降低污染並改善操作性能。

中型製造商和專業創新者透過專注於技術優勢來脫穎而出，例如獨特的密封機制、更佳的清潔性能以及可縮短連接時間的創新快速斷開設計。契約製造製造商和垂直整合供應商透過提供靈活的生產能力和聯合開發夥伴關係，加速差異化產品的上市，從而發揮戰略作用。同時，靈活的新興企業和醫療設備創新者專注於細分應用領域，瞄準家庭醫療保健和門診病人市場，提供量身定做的解決方案，以方便患者使用並降低生命週期成本。

成功的競爭對手強調合規性、透明的上市後監管以及與醫院採購週期相符的服務水準承諾。與經銷商和臨床專家夥伴關係能夠推動產品應用，而對訂單管理和可追溯性數位化工具的投資則有助於供應商在競爭激烈的採購環境中脫穎而出。

為製造商和醫療保健系統提供切實可行的策略建議，以增強產品採納率、供應鏈韌性和監管協調性。

產業領導者應優先採取一系列策略行動，以應對臨床需求、關稅帶來的成本壓力以及不斷變化的採購預期。首先，投資於產品設計改進，以顯著降低污染風險並改善使用者人體工學，同時輔以強力的臨床檢驗，從而建立買家信心。其次，透過利用近岸外包、雙重採購和合格的委託製造製造商等手段，實現生產和採購佈局多元化，以減輕關稅和供應中斷的影響，從而維持業務連續性。

第三，我們將加強監管和上市後監測能力，簡化跨轄區核准，並向機構投資者提供透明的安全資料。第四，我們將發展靈活的商業模式，包括直接合約、經銷商合作和數位化銷售管道，以滿足不同規模的訂單和採購偏好。第五，我們將透過提供培訓、技術服務和數據主導的庫存管理，提升售後服務，降低臨床風險，並最佳化存量基準。

協同執行這些措施能夠幫助企業保障淨利率、加速臨床應用並實現差異化。與臨床終端使用者和採購團隊的合作，可確保產品藍圖和商業策略與當地需求和機構限制相符。

一種透明且可重複的調查方法，結合了初步臨床訪談、二次藥物分析和三角驗證資料整合。

本分析的調查方法結合了定性和定量方法，以確保其嚴謹性和有效性。主要研究包括對臨床負責人、採購人員、供應商和監管專家進行結構化訪談，以獲取關於設備性能、採購促進因素和營運限制的第一手觀點。來自臨床現場的觀察回饋補充了相關人員的訪談，以檢驗關於設備操作、相容性和對現場工作流程影響的假設。

二級研究利用官方監管文件、產品說明書、專利文件和同行評審的臨床研究，全面了解了設備設計、材料科學和安全性能。競爭分析則利用產品目錄、分銷協議和第三方報告，描繪了市場策略和通路結構。資料整合採用跨來源三角驗證法，以調和臨床偏好和採購行為洞察之間的差異，並得出平衡的結論。

分析方法包括對訪談記錄進行定性編碼、對臨床需求進行主題分析以及建立供應鏈應急情境圖。在整個調查方法中，我們強調分析程序的透明度和可重複性，並透過同儕審查檢驗，以確保研究結果對臨床、商業和供應鏈相關人員具有實際應用價值。

對臨床優先事項、供應彈性以及監管協調進行綜合分析，將決定未來的應用和病人安全結果。

在急診環境中，無針連接器在臨床安全、器械工程和供應鏈管理方面佔據著至關重要的地位。現有證據表明，人們對能夠提供顯著感染控制效益、與輸液平台無縫相容以及可預測的供應連續性的器械期望日益成長。這些期望正在推動不同終端用戶群體和地理區域的需求差異，為那些能夠透過臨床檢驗證明產品性能並透過穩健的供應模式展現產品可用性的製造商創造了機會。

關稅主導的成本動態變化與日益嚴格的監管審查相結合，使得營運透明度和適應性籌資策略變得愈發重要。能夠將產品開發、法規遵循和商業性執行有機結合的組織，其績效將優於那些孤立處理各個環節的組織。因此，相關人員應將醫療設備的選擇和採購視為一個需要臨床、供應鏈和監管團隊通力合作的整合過程。

最終，製造商和醫療服務提供者現在做出的戰略選擇將影響未來數年的產品應用模式和病人安全結果。優先考慮具有臨床意義的創新、供應鏈韌性和清晰的監管路徑，是獲得永續競爭優勢和改善醫療服務的最直接途徑。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 為了最大限度地減少 ICU 環境中的污染，採用防腐屏障技術的封閉式魯爾鎖連接器正被擴大採用。
  • 重症加護中對壓力中性閉式迴路輸液裝置的需求不斷成長，以預防空氣栓塞。
  • 開發一種具有疏水性薄膜過濾器的整合式過濾過濾連接器，以降低急診環境中的感染率。
  • 轉向單手操作、低阻力無針連接器設計，以最佳化急診工作流程效率
  • 無針連接器與電子輸液幫浦和智慧醫院系統的兼容性對於提高安全性將變得越來越重要。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 按材料分類的急診無針連接器市場

  • 金屬
    • 鋁
    • 不銹鋼
  • 塑膠
    • 聚碳酸酯
    • 聚丙烯

9. 按最終用戶分類的急診無針連接器市場

  • 門診手術中心
    • 診所
    • 門診診斷中心
  • 家庭醫療保健
    • 家庭透析治療
    • 家庭輸液治療
  • 醫院
    • 二級護理
    • 三級醫療

10. 按連接器類型分類的急診無針連接器市場

  • 誘餌鎖
    • 女士
    • 男性
  • 誘餌滑
    • 女士
    • 男性
  • 快速斷開
    • 一件
    • 兩件套

第11章 按應用分類的急診無針連接器市場

  • 血液樣本採集
    • 動脈採樣
    • 靜脈取樣
  • 藥物遞送
    • 止痛藥
    • 抗生素
    • 化療
  • 點滴療法
    • Bolus輸液
    • 常規輸液

第12章 按分銷管道分類的急診無針連接器市場

  • 直銷
  • 經銷商
    • 醫療批發商
    • 第三方經銷商
  • 線上管道
    • 電子商務平台
    • 製造商網站

13. 各地區急診無針連接器市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 急診無針連接器市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 各國急診無針連接器市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Becton, Dickinson and Company
    • ICU Medical, Inc.
    • Smiths Medical, Inc.
    • B. Braun Melsungen AG
    • Teleflex Incorporated
    • Terumo Corporation
    • Nipro Corporation
    • Baxter International Inc.
    • Merit Medical Systems, Inc.
    • Vygon SA
Product Code: MRR-C002B1C99769

The Acute Care Needleless Connectors Market is projected to grow by USD 1,197.31 million at a CAGR of 7.59% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 666.55 million
Estimated Year [2025] USD 718.29 million
Forecast Year [2032] USD 1,197.31 million
CAGR (%) 7.59%

Needleless connectors have become central to safe vascular access in acute care environments, shaping clinical workflows, infection control practices, and procurement decisions across healthcare systems. These devices reduce the risks associated with needle use while enabling frequent access for therapies such as infusion and blood sampling. As clinicians and supply chain leaders navigate tighter budgets and higher expectations for safety and reliability, understanding device features, compatibility requirements, and lifecycle considerations has grown more important.

Over recent years, design refinements have prioritized leak prevention, ease of disinfection, and compatibility with standardized connection systems. These engineering advances intersect with evolving clinical protocols aimed at reducing central line-associated bloodstream infections and optimizing infusion accuracy. Consequently, stakeholders must balance clinical performance against device cost, regulatory compliance, and integration with existing infusion platforms.

This introduction frames the subsequent analysis by establishing the clinical imperatives and procurement realities that drive interest in needleless connectors. It sets the stage for deeper examination of market shifts, tariff impacts, segmentation dynamics, regional behaviors, and strategic responses that follow, providing readers with a clear orientation before moving into detailed findings and recommendations.

Transformative shifts in device innovation, infection control expectations, and supply chain strategies reshaping procurement and clinical adoption priorities

The landscape for needleless connectors is undergoing transformative shifts driven by technological refinement, heightened infection-prevention priorities, and supply chain recalibration. Innovations in materials and connector geometries have improved compatibility and reduced blood reflux, while adoption of standardized luer interfaces and quick-disconnect options has accelerated device interoperability across infusion systems. At the same time, risk-averse clinical governance has elevated device attributes such as ease of decontamination and failure-mode visibility, prompting purchasers to prioritize products that demonstrably reduce contamination risks.

Supply chain resilience has moved to the forefront as manufacturers and health systems respond to past disruptions and ongoing geopolitical uncertainties. Firms are increasingly diversifying sourcing strategies and qualifying alternate suppliers to mitigate single-source exposure. Regulatory scrutiny has evolved in parallel, with clearer expectations for device validation, post-market surveillance, and adverse-event transparency. This regulatory momentum elevates the value of vendors who can supply robust clinical evidence and traceability for their devices.

Taken together, these shifts change vendor selection criteria and accelerate consolidation among suppliers that can meet both clinical performance thresholds and rigorous procurement standards. As a result, healthcare organizations and manufacturers must adapt strategies across procurement, R&D, and regulatory engagement to sustain competitive positioning.

Assessment of the cumulative operational and procurement effects stemming from United States tariff measures implemented during 2025

Tariff adjustments implemented in the United States in 2025 have created a complex operating environment for manufacturers, distributors, and institutional buyers of needleless connectors. These policy changes have altered landed costs for imported assemblies and components, prompting manufacturers that previously relied heavily on cross-border sourcing to reassess their procurement footprints. In response, some producers have shifted toward nearshoring and dual-sourcing strategies to shield margins and maintain delivery reliability, while others have renegotiated supplier agreements or absorbed short-term cost increases to preserve customer relationships.

For distributors and hospital purchasing departments, the tariffs have compounded pressures to deliver value without compromising safety standards. Contract negotiations increasingly reflect tariff-exposed line items, and buyers now require greater line-item transparency to model total cost of ownership effectively. Clinicians and supply chain teams have therefore collaborated more closely to identify clinically equivalent alternatives that minimize financial impact while preserving device performance.

Regulatory and compliance functions have also felt secondary effects, as changes in manufacturing locations and supply chains necessitate updated documentation and, in some cases, additional validation activities. Consequently, organizations that proactively restructured manufacturing footprints or invested in supply chain visibility tools have navigated these changes more smoothly, preserving service levels and minimizing clinical disruption.

Comprehensive segmentation-driven insights integrating material choices, end-user environments, connector types, clinical applications, and distribution pathways

Segmentation analysis reveals multiple axes that determine product selection, purchasing behavior, and clinical deployment for needleless connectors. Material choices split broadly between metal and plastic construction, with metal variants covering aluminum and stainless steel options that offer durability and thermal stability, while plastic alternatives emphasize polycarbonate and polypropylene formulations that balance strength with cost-efficiency and compatibility with single-use protocols. This material differentiation influences sterilization pathways, device longevity, and perceived clinical robustness.

End-user segmentation further clarifies demand patterns across ambulatory surgical centers, home healthcare, and hospital environments. Ambulatory surgical centers encompass clinics and outpatient diagnostic centers where throughput and disposability often dominate purchasing logic, whereas home healthcare settings break down into home dialysis and home infusion therapy contexts that require devices optimized for patient handling, ease of use, and extended shelf-life. Hospitals include secondary and tertiary care facilities that prioritize infection control outcomes, integration with complex infusion regimens, and compatibility across diverse device inventories.

Connector type represents a crucial functional segmentation, covering luer lock, luer slip, and quick disconnect options. Luer lock and luer slip categories are each subdivided into female and male configurations that affect compatibility with syringes, catheters, and extension sets, while quick disconnect designs appear as one-piece or two-piece solutions that emphasize rapid connection and reliable sealing for high-frequency access scenarios. Application-based segmentation differentiates use cases such as blood sampling, drug delivery, and infusion therapy; blood sampling further distinguishes arterial from venous sampling, drug delivery separates analgesics, antibiotics, and chemotherapy therapies, and infusion therapy splits into bolus infusion and continuous infusion modalities that carry distinct performance requirements.

Distribution channel segmentation rounds out the picture by identifying direct sales, distributors, and online channels. Distributors comprise medical wholesalers and third-party distributors that serve institutional purchasers, while online channels include e-commerce platforms and manufacturer websites that facilitate faster replenishment and smaller order sizes. Each distribution pathway imposes different expectations for lead times, service levels, and documentation, thereby affecting how products are marketed and stocked across end-user segments.

Key regional behaviors and procurement dynamics shaping demand patterns across the Americas, Europe, Middle East & Africa, and Asia-Pacific territories

Regional dynamics shape product preferences, regulatory priorities, and supplier strategies across the Americas, Europe, Middle East & Africa, and Asia-Pacific geographies. In the Americas, large integrated delivery networks and centralized procurement models tend to emphasize cost effectiveness, interoperability with existing infusion platforms, and suppliers' ability to provide consistent national distribution. This region shows a preference for products that combine clinical evidence with scalable logistics solutions.

Europe, Middle East & Africa displays a heterogeneous regulatory and procurement landscape where national reimbursement policies, varying clinical protocols, and diverse supply chain maturities influence adoption rates. European markets often emphasize stringent conformity assessment and clinical documentation, while markets in the Middle East and Africa may prioritize availability and adaptability to local clinical practices. These differences require suppliers to tailor regulatory dossiers and commercial approaches by country or subregion.

Asia-Pacific presents distinct dynamics driven by rapid healthcare infrastructure expansion, significant growth in home healthcare services, and a wide range of manufacturing capabilities. Some markets in this region favor locally produced, cost-competitive products, while others seek premium devices with advanced features for tertiary hospitals. Across all regions, local regulatory engagement and partnerships with regional distributors remain critical to successful market entry and sustained adoption.

Strategic competitive intelligence revealing how leading manufacturers, specialized innovators, and supply partners drive differentiation through design, evidence, and service

Competitive behavior among leading companies in the needleless connector space reflects a balance of innovation, scale, and service capability. Market leaders leverage broad product portfolios, established distribution networks, and deep clinical evidence packages to support large institutional customers and multi-hospital systems. These firms invest in iterative product enhancements, user-centric design, and clinical studies that demonstrate reductions in contamination and improved handling characteristics.

Mid-tier manufacturers and specialist innovators differentiate through focused technical advantages, such as proprietary sealing mechanisms, improved flushability, or novel quick-disconnect designs that reduce connection time. Contract manufacturers and vertically integrated suppliers play a strategic role by offering flexible production capacity and co-development partnerships, enabling faster time-to-market for differentiated offerings. Meanwhile, agile start-ups and medical device innovators concentrate on niche applications, targeting home healthcare and outpatient segments with solutions tailored to patient usability and reduced lifecycle costs.

Across the competitive spectrum, successful companies emphasize regulatory readiness, transparent post-market surveillance, and service-level commitments that align with hospital procurement cycles. Partnerships with distributors and clinical champions frequently accelerate adoption, while investment in digital tools for order management and traceability differentiates vendors in tight procurement environments.

Actionable strategic recommendations for manufacturers and health systems to strengthen product adoption, supply resilience, and regulatory alignment

Industry leaders should prioritize a set of strategic actions to respond to clinical demands, tariff-induced cost pressures, and evolving procurement expectations. First, invest in product design improvements that demonstrate measurable reductions in contamination risk and improved user ergonomics, and pair those enhancements with robust clinical validation to build purchaser confidence. Second, diversify manufacturing and sourcing footprints to mitigate tariff exposure and supply interruptions, using nearshoring, dual sourcing, and qualified contract manufacturers as levers to maintain continuity.

Third, strengthen regulatory and post-market surveillance capabilities to streamline approvals across jurisdictions and to provide transparent safety data to institutional buyers. Fourth, develop flexible commercial models including direct contracts, distributor partnerships, and digital sales channels that accommodate varying order sizes and procurement preferences. Fifth, enhance after-sales support by offering training, technical service, and data-driven inventory management to reduce clinical risk and optimize stock levels at point of care.

By executing these measures in concert, companies can protect margins, accelerate clinical adoption, and create defensible differentiation. Collaboration with clinical end users and procurement teams will ensure that product roadmaps and commercial strategies remain aligned with frontline needs and institutional constraints.

Transparent and reproducible research methodology combining primary clinical interviews, secondary regulatory analysis, and triangulated data synthesis

The research methodology underpinning this analysis combined qualitative and quantitative approaches to ensure rigor and relevance. Primary research included structured interviews with clinical leaders, procurement directors, suppliers, and regulatory specialists to capture firsthand perspectives on device performance, purchasing drivers, and operational constraints. Observational inputs from clinical settings complemented stakeholder interviews to validate assumptions about device handling, compatibility, and frontline workflow impact.

Secondary research leveraged public regulatory filings, product instructions for use, patent literature, and peer-reviewed clinical studies to build a comprehensive view of device design, materials science, and safety performance. Competitive profiling relied on product catalogs, distribution agreements, and third-party reporting to map go-to-market strategies and channel structures. Data synthesis involved triangulation across sources, reconciling differences between clinical preference insights and procurement behavior to produce balanced conclusions.

Analytical methods incorporated qualitative coding of interview transcripts, thematic analysis of clinical requirements, and scenario mapping for supply chain contingencies. Throughout the methodology, emphasis was placed on transparency, reproducibility of analytical steps, and validation through expert review to ensure the findings are actionable for clinical, commercial, and supply chain stakeholders.

Concluding synthesis of clinical priorities, supply resilience, and regulatory alignment that will determine future adoption and patient safety outcomes

Needleless connectors occupy a vital intersection of clinical safety, device engineering, and supply chain management within acute care environments. The collective evidence points to rising expectations for devices that deliver demonstrable infection control benefits, seamless compatibility across infusion platforms, and predictable supply continuity. These expectations drive differentiated demand across end-user segments and regions and create opportunities for manufacturers able to prove performance through clinical validation and deliverability through resilient supply models.

The intersection of tariff-driven cost dynamics and heightened regulatory scrutiny increases the premium on operational transparency and adaptive sourcing strategies. Organizations that align product development, regulatory readiness, and commercial execution will outperform those that treat these elements in isolation. Consequently, stakeholders should view device selection and procurement as an integrated process requiring collaboration among clinical, supply chain, and regulatory teams.

In closing, the strategic choices made by manufacturers and healthcare providers today will shape adoption patterns and patient safety outcomes over the coming years. Prioritizing clinically meaningful innovation, supply chain resilience, and clear regulatory pathways offers the most direct route to sustainable competitive advantage and improved care delivery.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of closed male luer lock connectors with antiseptic barrier technology to minimize contamination in ICU settings
  • 5.2. Increasing demand for closed system transfer devices with pressure-neutral designs to prevent air embolism in critical care
  • 5.3. Development of integrated filtration needleless connectors with hydrophobic membrane filters to lower infection rates in acute care
  • 5.4. Shift towards low-resistance one-handed operable needleless connector designs to optimize workflow efficiency in emergency departments
  • 5.5. Growing emphasis on compatibility of needleless connectors with electronic infusion pumps and smart hospital systems for improved safety

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Acute Care Needleless Connectors Market, by Material

  • 8.1. Metal
    • 8.1.1. Aluminum
    • 8.1.2. Stainless Steel
  • 8.2. Plastic
    • 8.2.1. Polycarbonate
    • 8.2.2. Polypropylene

9. Acute Care Needleless Connectors Market, by End User

  • 9.1. Ambulatory Surgical Center
    • 9.1.1. Clinics
    • 9.1.2. Outpatient Diagnostic Center
  • 9.2. Home Healthcare
    • 9.2.1. Home Dialysis
    • 9.2.2. Home Infusion Therapy
  • 9.3. Hospital
    • 9.3.1. Secondary Care
    • 9.3.2. Tertiary Care

10. Acute Care Needleless Connectors Market, by Connector Type

  • 10.1. Luer Lock
    • 10.1.1. Female
    • 10.1.2. Male
  • 10.2. Luer Slip
    • 10.2.1. Female
    • 10.2.2. Male
  • 10.3. Quick Disconnect
    • 10.3.1. One-Piece
    • 10.3.2. Two-Piece

11. Acute Care Needleless Connectors Market, by Application

  • 11.1. Blood Sampling
    • 11.1.1. Arterial Sampling
    • 11.1.2. Venous Sampling
  • 11.2. Drug Delivery
    • 11.2.1. Analgesics
    • 11.2.2. Antibiotics
    • 11.2.3. Chemotherapy
  • 11.3. Infusion Therapy
    • 11.3.1. Bolus Infusion
    • 11.3.2. Continuous Infusion

12. Acute Care Needleless Connectors Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
    • 12.2.1. Medical Wholesalers
    • 12.2.2. Third-Party Distributors
  • 12.3. Online Channels
    • 12.3.1. E-Commerce Platforms
    • 12.3.2. Manufacturer Websites

13. Acute Care Needleless Connectors Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Acute Care Needleless Connectors Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Acute Care Needleless Connectors Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Becton, Dickinson and Company
    • 16.3.2. ICU Medical, Inc.
    • 16.3.3. Smiths Medical, Inc.
    • 16.3.4. B. Braun Melsungen AG
    • 16.3.5. Teleflex Incorporated
    • 16.3.6. Terumo Corporation
    • 16.3.7. Nipro Corporation
    • 16.3.8. Baxter International Inc.
    • 16.3.9. Merit Medical Systems, Inc.
    • 16.3.10. Vygon SA

LIST OF FIGURES

  • FIGURE 1. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY CONNECTOR TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY CONNECTOR TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. ACUTE CARE NEEDLELESS CONNECTORS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. ACUTE CARE NEEDLELESS CONNECTORS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ACUTE CARE NEEDLELESS CONNECTORS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY METAL, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY METAL, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY METAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY METAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY METAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY METAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY METAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY METAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ALUMINUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ALUMINUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ALUMINUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ALUMINUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ALUMINUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ALUMINUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY PLASTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY PLASTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY PLASTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY PLASTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY POLYCARBONATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY POLYCARBONATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY POLYCARBONATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY POLYCARBONATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY POLYCARBONATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY POLYCARBONATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY OUTPATIENT DIAGNOSTIC CENTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY OUTPATIENT DIAGNOSTIC CENTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY OUTPATIENT DIAGNOSTIC CENTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY OUTPATIENT DIAGNOSTIC CENTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY OUTPATIENT DIAGNOSTIC CENTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY OUTPATIENT DIAGNOSTIC CENTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOME HEALTHCARE, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOME DIALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOME DIALYSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOME DIALYSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOME DIALYSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOME DIALYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOME DIALYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOME INFUSION THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOME INFUSION THERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOME INFUSION THERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOME INFUSION THERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOME INFUSION THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOME INFUSION THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY SECONDARY CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY SECONDARY CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY SECONDARY CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY SECONDARY CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY SECONDARY CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY SECONDARY CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY TERTIARY CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY TERTIARY CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY TERTIARY CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY TERTIARY CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY TERTIARY CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY TERTIARY CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY CONNECTOR TYPE, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY CONNECTOR TYPE, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY LUER LOCK, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY LUER LOCK, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY LUER LOCK, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY LUER LOCK, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY LUER LOCK, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY LUER LOCK, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY LUER LOCK, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY LUER LOCK, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY FEMALE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY FEMALE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY FEMALE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY FEMALE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY FEMALE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY FEMALE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MALE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MALE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MALE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MALE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MALE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MALE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY LUER SLIP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY LUER SLIP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY LUER SLIP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY LUER SLIP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY LUER SLIP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY LUER SLIP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY LUER SLIP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY LUER SLIP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY FEMALE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY FEMALE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY FEMALE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY FEMALE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY FEMALE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY FEMALE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MALE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MALE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MALE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MALE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MALE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MALE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY QUICK DISCONNECT, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY QUICK DISCONNECT, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY QUICK DISCONNECT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY QUICK DISCONNECT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY QUICK DISCONNECT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY QUICK DISCONNECT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY QUICK DISCONNECT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY QUICK DISCONNECT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ONE-PIECE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ONE-PIECE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ONE-PIECE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ONE-PIECE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ONE-PIECE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ONE-PIECE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY TWO-PIECE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY TWO-PIECE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY TWO-PIECE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY TWO-PIECE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY TWO-PIECE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY TWO-PIECE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY BLOOD SAMPLING, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY BLOOD SAMPLING, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY BLOOD SAMPLING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY BLOOD SAMPLING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY BLOOD SAMPLING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY BLOOD SAMPLING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY BLOOD SAMPLING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY BLOOD SAMPLING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ARTERIAL SAMPLING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ARTERIAL SAMPLING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ARTERIAL SAMPLING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ARTERIAL SAMPLING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ARTERIAL SAMPLING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ARTERIAL SAMPLING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY VENOUS SAMPLING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY VENOUS SAMPLING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY VENOUS SAMPLING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY VENOUS SAMPLING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY VENOUS SAMPLING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY VENOUS SAMPLING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DRUG DELIVERY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DRUG DELIVERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DRUG DELIVERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ANALGESICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ANALGESICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ANALGESICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ANALGESICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ANALGESICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ANTIBIOTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ANTIBIOTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ANTIBIOTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ANTIBIOTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY CHEMOTHERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY CHEMOTHERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY CHEMOTHERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY CHEMOTHERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY INFUSION THERAPY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY INFUSION THERAPY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY INFUSION THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY INFUSION THERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY INFUSION THERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY INFUSION THERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY INFUSION THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY INFUSION THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY BOLUS INFUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY BOLUS INFUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY BOLUS INFUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY BOLUS INFUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY BOLUS INFUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY BOLUS INFUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY CONTINUOUS INFUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY CONTINUOUS INFUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY CONTINUOUS INFUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY CONTINUOUS INFUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY CONTINUOUS INFUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY CONTINUOUS INFUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DISTRIBUTORS, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MEDICAL WHOLESALERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MEDICAL WHOLESALERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MEDICAL WHOLESALERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MEDICAL WHOLESALERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MEDICAL WHOLESALERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MEDICAL WHOLESALERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ONLINE CHANNELS, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ONLINE CHANNELS, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY E-COMMERCE PLATFORMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY E-COMMERCE PLATFORMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY E-COMMERCE PLATFORMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY E-COMMERCE PLATFORMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MANUFACTURER WEBSITES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MANUFACTURER WEBSITES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MANUFACTURER WEBSITES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MANUFACTURER WEBSITES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MANUFACTURER WEBSITES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARK